AMTX vs MNTK

AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite a 14.2% YoY revenue growth and recent positive EPS surprises, the company remains unprofitable with negative cash flow and extreme liquidity issues (current ratio of 0.07). The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and deteriorating balance sheet. The 52-week price range of $1.22–$3.66 reflects high volatility and speculative risk.

MNTK presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a severe valuation disconnect, with the current price ($1.19) trading significantly above both the Graham Number ($0.64) and the growth-based Intrinsic Value ($0.07). While the company exhibits impressive top-line revenue growth of 56.7% and a promising Forward P/E of 5.61, these are offset by a disastrous long-term price trend (-88.6% over 5 years) and a technical trend score of 0/100. The company is struggling to convert high gross margins (37.3%) into operating profitability, as evidenced by a negative operating margin of -2.05%.